These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31898163)

  • 1. Five-year follow-up of patients treated with intra-dermal botulinum toxin for axillary hyperhidrosis.
    Lynch OE; Aherne T; Gibbons J; Boland MR; Ryan ÉJ; Boyle E; Egan B; Tierney S
    Ir J Med Sci; 2020 Aug; 189(3):1023-1026. PubMed ID: 31898163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study between intradermal botulinum toxin A and fractional microneedle radiofrequency (FMR) for the treatment of primary axillary hyperhidrosis.
    Rummaneethorn P; Chalermchai T
    Lasers Med Sci; 2020 Jul; 35(5):1179-1184. PubMed ID: 31939036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study.
    Campanati A; Penna L; Guzzo T; Menotta L; Silvestri B; Lagalla G; Gesuita R; Offidani A
    Clin Ther; 2003 Jan; 25(1):298-308. PubMed ID: 12637128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial.
    Naumann MK; Hamm H; Lowe NJ;
    Br J Dermatol; 2002 Dec; 147(6):1218-26. PubMed ID: 12452874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase.
    Karamfilov T; Konrad H; Karte K; Wollina U
    Arch Dermatol; 2000 Apr; 136(4):487-90. PubMed ID: 10768647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ
    J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.
    Naumann M; Lowe NJ
    BMJ; 2001 Sep; 323(7313):596-9. PubMed ID: 11557704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
    Rosell K; Hymnelius K; Swartling C
    Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum A neurotoxin for axillary hyperhidrosis. No sweat Botox.
    Glogau RG
    Dermatol Surg; 1998 Aug; 24(8):817-9. PubMed ID: 9723044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palmar and axillary hyperhidrosis treated with botulinum toxin: one-year clinical follow-up.
    Naver H; Swartling C; Aquilonius SM
    Eur J Neurol; 2000 Jan; 7(1):55-62. PubMed ID: 10809915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of axillary hyperhidrosis with botulinum-A toxin.
    Salmanpoor R; Rahmanian MJ
    Int J Dermatol; 2002 Jul; 41(7):428-30. PubMed ID: 12121560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin in the treatment of axillary hyperhidrosis.
    Galadari I; Alkaabi J
    Skinmed; 2003; 2(4):209-11. PubMed ID: 14673273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum A toxin improves life quality in severe primary focal hyperhidrosis.
    Swartling C; Naver H; Lindberg M
    Eur J Neurol; 2001 May; 8(3):247-52. PubMed ID: 11328333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with botulinum toxin therapy for axillary hyperhidrosis and comparison to modelled data for endoscopic thoracic sympathectomy - A quality of life and cost effectiveness analysis.
    Gibbons JP; Nugent E; O'Donohoe N; Maher B; Egan B; Feeley M; Tierney S
    Surgeon; 2016 Oct; 14(5):260-4. PubMed ID: 26071930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis: efficacy and duration with repeated treatments.
    Lowe PL; Cerdan-Sanz S; Lowe NJ
    Dermatol Surg; 2003 May; 29(5):545-8. PubMed ID: 12752526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of Efficacy Increases with the Repetition of Botulinum Toxin A Injections in Primary Axillary Hyperhidrosis: A 15-year Study in 117 Patients.
    Berthin C; Maillard H
    Acta Derm Venereol; 2019 Dec; 99(13):1237-1240. PubMed ID: 31453629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of the efficacy of dermal botulinium toxin for primary axillary hyperhidrosis.
    Hanlon L; Cahill R; Barry MC
    Ir J Med Sci; 2006; 175(1):57-8. PubMed ID: 16615232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of axillary hyperhidrosis with botulinum toxin: a single surgeon's experience with 53 consecutive patients.
    Doft MA; Kasten JL; Ascherman JA
    Aesthetic Plast Surg; 2011 Dec; 35(6):1079-86. PubMed ID: 21559989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M; Lowe NJ; Kumar CR; Hamm H;
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and prolonged efficacy of Botulin Toxin A in primary hyperhidrosis.
    D'Epiro S; Macaluso L; Salvi M; Luci C; Mattozzi C; Marzocca F; Salvo V; Scarnò M; Calvieri S; Richetta AG
    Clin Ter; 2014; 165(6):e395-400. PubMed ID: 25524193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.